Back to search

Article

Pan-Cancer Biomarker Analysis from the Cancer Dependency Map: A Blueprint for Precision Oncology

2025-02-10

Abstract excerpt

The diversity of therapeutic modalities and targets continue to grow, and the number of cancer patients eligible for targeted therapy has expanded accordingly. Despite advances, response rates to individual targeted therapy drugs remain variable, rarely achieving uniform tumor shrinkage across patients. Biomarkers are crucial for identifying patients likely to respond to therapy while sparing non-responders from t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c6f3cc8-b397-5cc4-b0bf-9baf122601a9
DOI
10.1101/2025.02.07.637152
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-Cancer Biomarker Analysis from the Cancer Dependency Map: A Blueprint for Precision OncologyDOI 10.1101/2025.02.07.637152
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.Semantic proximity
Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical OncologySemantic proximity
The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity
Cancer Treatment in the Genomic EraSemantic proximity
Integrative omics analyses broaden treatment targets in human cancer.Semantic proximity
Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screensSemantic proximity
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity
The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity
Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity
Cancer biomarker discovery and validation.Semantic proximity
Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity
Personalized Cancer Therapy Prioritization Based on Driver Alteration Co-occurrence PatternsSemantic proximity
Select a neighboring publication to make it the new centre.